Stock Track | MindMed Shares Soar on Upbeat Earnings and Bullish Analyst Actions

Stock Track2024-11-10

Shares of Mind Medicine (MindMed) Inc. (MNMD) surged by a remarkable 21.01% on Thursday, November 8th, driven by the company's better-than-expected quarterly results and bullish actions from analysts.

MindMed, a leading player in the emerging field of psychedelic drug development, reported an adjusted loss of $0.27 per share for the quarter ended September 30. This figure came in narrower than analysts' expectations of a $0.28 per share loss, surprising investors and sparking enthusiasm about the company's performance.

Following the earnings release, several analysts raised their price targets and ratings on MindMed, further fueling the stock's rally. Canaccord Genuity boosted its price target to $16 from $14, while maintaining a Buy rating on the shares. Similarly, RBC Capital Markets increased its target to $21 from $20, also reiterating its Outperform rating.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1189305993?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-10 23:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1189305993","market":"hk","top_or_hot":-1,"title":"Stock Track | MindMed Shares Soar on Upbeat Earnings and Bullish Analyst Actions","media":"Stock Track","content":"<p>Shares of Mind Medicine (MindMed) Inc. (MNMD) surged by a remarkable 21.01% on Thursday, November 8th, driven by the company's better-than-expected quarterly results and bullish actions from analysts.</p>\n\n<p>MindMed, a leading player in the emerging field of psychedelic drug development, reported an adjusted loss of $0.27 per share for the quarter ended September 30. This figure came in narrower than analysts' expectations of a $0.28 per share loss, surprising investors and sparking enthusiasm about the company's performance.</p>\n\n<p>Following the earnings release, several analysts raised their price targets and ratings on MindMed, further fueling the stock's rally. Canaccord Genuity boosted its price target to $16 from $14, while maintaining a Buy rating on the shares. Similarly, RBC Capital Markets increased its target to $21 from $20, also reiterating its Outperform rating.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | MindMed Shares Soar on Upbeat Earnings and Bullish Analyst Actions</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | MindMed Shares Soar on Upbeat Earnings and Bullish Analyst Actions\n</h2>\n\n<h4 class=\"meta\">\n\n2024-11-10 23:46 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Mind Medicine (MindMed) Inc. (MNMD) surged by a remarkable 21.01% on Thursday, November 8th, driven by the company's better-than-expected quarterly results and bullish actions from analysts....</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MNMD","symbol_name":"Mind Medicine (MindMed) Inc.","start_time":0,"source_url":"","article_id":"1189305993","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1189305993","pubTimestamp":1731253592,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Mind Medicine  Inc.  surged by a remarkable 21.01% on Thursday, November 8th, driven by the company's better-than-expected quarterly results and bullish actions from analysts.MindMed, a leading player in the emerging field of psychedelic drug development, reported an adjusted loss of $0.27 per share for the quarter ended September 30. This figure came in narrower than analysts' expectations of a $0.28 per share loss, surprising investors and sparking enthusiasm about the company's perf","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MNMD":"Mind Medicine (MindMed) Inc."},"translate_title":"股票追踪MindMed股价因乐观的盈利和看涨的分析师行动而飙升","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MNMD":1},"content_text":"Shares of Mind Medicine (MindMed) Inc. (MNMD) surged by a remarkable 21.01% on Thursday, November 8th, driven by the company's better-than-expected quarterly results and bullish actions from analysts.\nMindMed, a leading player in the emerging field of psychedelic drug development, reported an adjusted loss of $0.27 per share for the quarter ended September 30. This figure came in narrower than analysts' expectations of a $0.28 per share loss, surprising investors and sparking enthusiasm about the company's performance.\nFollowing the earnings release, several analysts raised their price targets and ratings on MindMed, further fueling the stock's rally. Canaccord Genuity boosted its price target to $16 from $14, while maintaining a Buy rating on the shares. Similarly, RBC Capital Markets increased its target to $21 from $20, also reiterating its Outperform rating.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1189305993"}